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Saturated Fatty Acid Increases Lung Macrophages
and Augments House Dust Mite-Induced Airway Inflammation
in Mice Fed with High-Fat Diet
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Shinya Kimura,1 and Naoko Sueoka-Aragane1
Abstract—Obesity is one of the phenotypes of severe asthma, which is considered to be a heterogeneous
syndrome; however, its interaction with airway inflammation is not fully understood. The aim of this
study was to clarify the role of saturated fatty acids in augmenting airway inflammation induced by h-
ouse dust mite (HDM) in obesity. Subjects were Balb/c mice fed a high-fat diet (HFD) for 10 weeks,
followed by sensitization and exposure to HDM. Subjects were also administered palmitic acid (PA) for
4 weeks with concurrent sensitization and exposure to HDM. Airway inflammation was assessed by
quantifying the amount of inflammatory cells in bronchoalveolar lavage (BAL) and airway resistance
was measured. In vitro, lipopolysaccharide (LPS)-primed macrophages were stimulated by PA. The
amount of monocyte chemoattractant protein-1 (MCP-1), interleukin-1β (IL-1β), and tumor necrosis
factor α (TNF-α) was examined in the supernatant. Compared to normal chow mice, HFD mice
underwent significant increases in body weight; increases in number of lung macrophages, including
circulating monocytes and alveolar macrophages; and increases in bronchoalveolar lavage fluid (BALF)
total cell count, including neutrophils but not eosinophils, after HDM sensitization and exposure.
In vitro, PA induced MCP-1 and augmented LPS-primed production of IL-1β and TNF-α in macro-
phages. Among HDM mice that were administered PA, there was an increase BALF total cell count,
including neutrophils but not eosinophils, compared to vehicle mice. In conclusion, saturated fatty acid
increased the number of lung macrophages and augmented HDM-induced neutrophilic airway inflam-
mation in a HFD mouse model.
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INTRODUCTION
Bronchial asthma is a common respiratory disease
that involves eosinophilic airway inflammation in-
duced by sensitization and exposure to antigens, such
as house dust mite (HDM) [14, 23]. Inhaled cortico-
steroid (ICS), which is the principal medication for the
treatment of asthma, has contributed to disease control
and reduction of mortality for the past 20 years [47].
However, 5% to 10% of cases that are refractory to
standard treatment are identified as severe asthma [8,
27, 35]. Severe asthma is characterized by uncontrolled
symptoms, frequent exacerbations, airflow limitation,
and airway inflammation [28, 46]. As a result, patients
with severe asthma need higher cost of medical treat-
ment than those with mild asthma [1, 2]. Severe asthma
is considered to be a heterogeneous syndrome that has
features of early-onset atopic factor, late-onset
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eosinophilic airway inflammation, neutrophilic airway
inflammation, and obesity [35, 46]. Basic as well as
clinical research has shown that obesity is an important
phenotype of severe asthma [3, 20, 34, 38]. In addition,
asthmatic patients who are obese do not respond as
well to ICS as patients with normal body mass index
(BMI) [4, 33, 39]. In fact, weight loss was shown to
improve airway hyperresponsiveness (AHR) and
symptom control in obese asthmatic patients [11, 12].
These studies implied that the extent of obesity and the
severity of asthma are closely related; however, the
interaction between obesity and the pathogenesis of
asthma, including airway inflammation, is not fully
understood.
Obesity itself is considered an inflammatory dis-
ease [45] that is associated with other low-grade sys-
temic inflammatory diseases, such as metabolic syn-
drome, type 2 diabetes, non-alcoholic fatty liver, and
cardiovascular disease [17, 43]. In previous studies,
animal models were administered a high-fat diet
(HFD) to induce obesity so that the interaction between
obesity and inflammation could be analyzed [15, 18,
22]. Overconsumption of saturated fatty acids (SFA),
which compose a HFD, was discovered to be a risk
factor for obesity-related diseases [13, 37]. SFA in-
duces inflammatory molecules, such as tumor necrosis
factor α (TNF-α), interleukin (IL)-1β, IL-6, monocyte
chemoattractant protein-1 (MCP-1), and macrophage
inhibitory factor through toll-like receptor 4 (TLR4)
[36, 44, 52], and regulates organ inflammation through
macrophage recruitment [9, 50]. According to these
data, increased amount of SFA in obese individuals
would lead to inflammation in various organs.
In the present study, an increased number of lung
macrophages were observed in a HFD mouse model.
HDM-induced mice with augmented neutrophilic air-
way inflammation and AHR were found to have ele-
vated levels of IL-17A and macrophage inflammatory
protein 2 (MIP2) after receiving a HFD for 10 weeks.
Palmitic acid (PA), which is the main SFA component
of HFD, directly induced inflammatory cytokine and
chemokine production from macrophages. Finally, we
demonstrated that similar to administration of HFD,
administration of PA to mice increased the number of
lung macrophages and augmented HDM-induced neu-
trophilic airway inflammation and AHR. To the best of
our knowledge, this was the first report that demon-
strated SFA-augmented pathogenesis of asthma in an
obese mouse model; this observation was associated
with lung macrophages, which are likewise considered
to enhance the mechanism of obese asthma.
MATERIALS AND METHODS
Allergen and Chemicals
HDM extracts from Dermatophagoides farinae
(Der f) were purchased from ITEA Inc. (Tokyo, Japan).
PA (Sigma-Aldrich, Saint Louis, MO, USA) was dis-
solved in 50% ethanol at 60 °C to yield a 50-mM stock
concentration, which was kept at −20 °C. PA was
diluted to the appropriate concentration using 1% fatty
acid-free bovine serum albumin (BSA) at 37 °C. The
endotoxin level in the PA solution was less than the
detection limit of 0.0015 EU/ml by the assay kit (Lim-
ulus ES-2, Wako, Japan).
Mice
Female BALB/c mice (Japan SLC Inc.; Hamamatsu,
Japan) aged 3–6 weeks were kept at the Saga University
animal facility under specific pathogen-free conditions.
Animal experiments were undertaken following the guide-
lines for care and use of experimental animals by the
Japanese Association for Laboratory Animals Science
(1987) and were approved by the Saga University Animal
Care and Use Committee.
Administration of High-Fat Diet and Palmitic Acid
Starting at 3 weeks of age, female mice were fed
with either normal chow or an HFD for 10 weeks. The
HFD (D12492; Research Diets Inc., New Brunswick,
NJ) provided 60% of energy in the form of fat. At the
age of 6 weeks, BSA or 50-μM (150 μl) palmitate–
BSA complex was administered by intraperitoneal in-
jection five times per week for 4 weeks. Body weight
was measured every week.
Protocol for House Dust Mite-Induced Airway Inflam-
mation in Mice Administered with High-Fat Diet or
Palmitic Acid
In the HFD model, mice aged 3 weeks were fed
normal chow or HFD for total 10 weeks. After 7 weeks
of HFD intake, mice were sensitized by intranasal
administration of 25 μg HDM or phosphate-buffered
saline (PBS) once a week for 3 weeks. At 10 weeks of
HFD intake, mice were exposed to continuous
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intranasal administration of 5 μg HDM or PBS for
3 days. In the PA mouse model aged 6 weeks,
50 μM (150 μl) of palmitate–BSA complex or a BSA
vehicle was administered by intraperitoneal injection
five times per week for 4 weeks. Sensitization was
done by intranasal administration of 25 μg HDM or a
vehicle on days 2, 9, and 16. Exposure was carried out
by intranasal administration of 5 μg HDM or a vehicle
on days 23, 24, and 25. On days with simultaneous PA
and HDM administration, PA was given 30 min before
HDM inoculation. For all these models, mice were
euthanized by intraperitoneal injection of sodium pen-
tobarbital 24 h after the final exposure. Bronchoalveo-
lar lavage fluid (BALF) and lung tissue were collected
for further analyses.
Isolation of Single Cells from Lung Tissue
Peripheral lung tissue was cut into small pieces then
transferred through a 70-μm mesh before processing in a
digestion buffer that included deoxyribonuclease I
(Invitrogen, Waltham, MA) and collagenase type 2
(Worthington Inc., Lakewood, NJ). The remaining red cells
were lysed using BD Pharm Lysis (BD Biosciences, San
Jose, CA) to obtain single-cell suspensions.
Flow Cytometry
Single-cell suspensions were pre-incubated with
FcγR-specific blocking mAb and washed before staining.
Cells were stained with CD11b, CD11c, CD45, and Ly6c
(eBioscience, San Diego, CA) before collection on a flow
cytometer (FACS Aria 2; BD Bioscience, Franklin Lakes,
NJ) and analysis by FlowJo 8.3.3 software (Tree Star,
Ashland, OR).
Collection of Bronchoalveolar Lavage Fluid
BALF samples were collected, as described previous-
ly [21, 40]. Briefly, a 20-G tube was inserted in the trachea,
followed by two times of lung lavage with 1 ml of saline.
The cell suspension was centrifuged at 100×g for 5 min at
4 °C. The total number of cells was counted using a
hemocytometer. Cytospin samples were prepared from
the cell suspension. Cell differentiation was determined
by counting at least 300 leukocytes in samples stained with
Diff-Quik (Siemens, Germany).
Airway Hyperresponsiveness to Methacholine
Briefly, mice were anesthetized with pentobarbital
before insertion of an 18-G metal needle into an
exposed trachea, which was connected to a forced
oscillation technique (flexiVent system; SCIREQ Inc.,
Montreal, Canada). Next, their lungs were inflated to a
pressure of 30 cmH2O; baseline recordings were ob-
tained using a single frequency (2.5 Hz, 1.2 s; Snap-
shot-150) and a broadband low frequency (1–20.5 Hz,
3 s; Quick-Prime-3). The mice were then exposed to an
aerosol of PBS. All parameters calculated from both
test signals were recorded alternately every 10 s for
3 min. Finally, two deep lung inflations were given.
The above protocol was repeated for five times more
with aerosols containing sequentially increasing con-
centrations of 0.1, 1.0, 10, 20, and 50 mg/ml
methacholine (Sigma-Aldrich, Japan).
Hematoxylin–Eosin and Periodic Acid-Schiff Histology
Examination
Histologic examination was performed, as previously
reported [16]. Lungs were fixed with 10% neutral-buffered
formalin (Wako, Japan) and embedded in paraffin. Lung
sections were stained with hematoxylin and eosin (H&E)
and periodic acid-Schiff (PAS).
Preparation of Lung Homogenates
After BAL, the left lung was isolated and homogenized
in 50-mM Tris-buffered saline (pH 7.4) containing 1 mM
ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl
fluoride, 1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 mM
Na3VO4, and 1 mM NaF. The lung homogenates were cen-
trifuged at 10,000×g for 15 min; supernatants were collected
and stored at −80 °C until needed.
Quantification of Cytokines Using Enzyme-Linked
Immunosorbent Assay
IL-13, TNF-α, IL-1β, IL-17A, MCP-1, and MIP2
were measured using enzyme-linked immunosorbent assay
(ELISA) Kits (R&D Systems Inc., Minneapolis, MN),
according to the manufacturers’ instructions. All samples
were tested in duplicate.
Cell Culture of RAW 264.7, Bone Marrow
Macrophages, and Peritoneal Macrophages
RAW 264.7 was grown in an RPMI 1640 medium
containing 10% fetal calf serum (FCS). Bone marrow
(BM) cells were isolated from BALB/c mice, as previ-
ously reported [41], and were suspended at 1.0 × 106
cells/ml in RPMI 1640 medium supplemented with
10% FCS. The cells were cultured in the presence of
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10 ng/ml recombinant murine macrophage colony-
stimulating factor (M-CSF) (R&D Systems Inc., Min-
neapolis, MN) at 37 °C in a humidified atmosphere
containing 5% carbon dioxide for 6 days. On day 6,
cells were harvested and cultured as BM-derived mac-
rophages (BMMs). To obtain fresh peritoneal macro-
phages, mice were injected intraperitoneally with 1 ml
thioglycollate (3%). After 4 days, peritoneal fluid was
obtained by lavage with 10 ml PBS. The fluid was
centrifuged to isolate peritoneal macrophages, which
were re-suspended in RPMI 1640 medium. These cells
were cultured at a density of 1 × 106 cells in RPMI
1640 containing FCS and were stimulated as indicated
in Fig. 3. RNA was isolated after 8 h and the
supernatant was analyzed by ELISA after 24 h.
RNA Extraction and Quantitative PCR
RNA was extracted from RAW 264.7 using the
RNeasy Protect Mini Kit (QIAGEN, Netherlands);
assessed by quantity and quality using a NanoDrop
1000A spectrophotometer (NanoDrop Products, Wil-
mington, DE, USA); and was reverse transcribed to
cDNA. Taqman gene expression assays were used to
detect TLR4 (Mm00445273-m1 Tlr4) and 18S RNA
(Mm03928990-g1 Rn18s). Messenger RNA expression
levels were standardized using 18S RNA expression.
Statistical Analysis
Data were presented as mean ± standard deviation
(SD). Differences between two groups were analyzed
by Student’s t test. Multiple comparisons of continuous
variables were analyzed using one-way analysis of
variance, followed by a post hoc Tukey–Kramer test
for multiple groups. Significance was set at a p value
of 0.05.
RESULTS
High-Fat Diet Increased Body Weight and Lung
Macrophages but Not Airway Inflammation and
Hyperresponsiveness
To clarify the interaction between obesity and
asthma, we initially focused on the lung cell population
of HFD mice (Fig. 1a). The body weight of HFD mice
significantly increased compared with that of normal
chow mice (Fig. 1b). The appearance of HFD mice is
shown in Fig. 1c. To identify the lung cell population
in HFD mice, we examined single-cell suspensions by
flow cytometry (Fig. 1d). Lung macrophages were
classified as recruited monocytes from the systemic
circulation (circulating monocytes) or resident macro-
phages (alveolar macrophages). In the analysis, circu-
lating monocytes and alveolar macrophages were sig-
nificantly increased in the lungs of HFD mice com-
pared with normal chow mice (Fig. 1e, f). Circulating
monocytes were characterized by the surface markers
CD45+; CD11c−; CD11b+; and Ly6c+; whereas as
alveolar macrophages were CD45+; CD11c+; and
CD11b−. The total cell count and differential count in
BALF were not different between HFD mice and
normal chow mice. AHR also showed no difference
between these groups (data not shown). These results
suggested that HFD increased the number of lung
macrophages, including circulating monocytes and
alveolar macrophages, but not airway inflammation
and AHR.
High-Fat Diet Augmented House Dust Mite-Induced
Neutrophilic Airway Inflammation, Airway
Hyperresponsivenes, and Cytokine Production in the
Lungs
We investigated the association of HFD with airway
inflammation, AHR, and cytokine level in HDM-induced
mice (Fig. 2a). The body weights of PBS-HFD and HDM-
HFD mice were significantly higher than those of PBS-
chow and HDM-chow mice (Fig. 2b). BALF total cell
count, neutrophils, and eosinophils were significantly
higher in HDM-chow and HDM-HFD mice than in PBS-
chow and PBS-HFD mice (Fig. 2c). Additionally, among
the HDM mice, the BALF total cell count and neutrophils,
not eosinophils, were significantly increased in HFD mice
compared to chow mice (Fig. 2c). Airway resistance, rep-
resented by AHR, was higher in HDM-chow mice than in
PBS-chow and PBS-HFD mice and was significantly
higher in HDM-HFD mice than in HDM-chow mice
(Fig. 2d).
Fig. 1. HFD increases body weight and number of lung macrophages. a
Protocol of feeding normal chow or HFD to mice for 10 weeks. Compar-
ison of b body weight gain (n = 6 in each group) and c representative pi-
ctures of normal chow and HFDmice. d Cells are identified from digested
lungs; after exclusion of doublets and debris, leukocytes are separated by
CD45 staining. CD11c-negative, CD11b-positive, and Ly6c-positive cells
are identified on circulating monocytes. On the other hand, CD11c-
positive and CD11b-negative cells are identified on alveolar macrophages.
The percentages of e circulating monocytes and f alveolar macrophages
are compared between normal chow and HFD mice. **P < 0.01. HFD,
high-fat diet.
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Saturated Fatty Acid and Airway Inflammation
On pathologic examination of the lungs, inflam-
matory cells and goblet cell hyperplasia were intensely
seen in HDM-normal chow mice and HDM-HFD mice
compared with PBS-chow mice and PBS-HFD mice.
The findings in HDM-HFD mice tended to be more
intense than those in HDM-chow mice (Fig. 2e). The
levels of cytokines IL-13, IL-17A, IL-1β, and MIP2 in
lung tissue were increased in HDM-chow and HDM-
HFD mice compared with PBS-chow and PBS-HFD
mice. IL-17A and MIP2, but not IL-13 and IL-1β,
were significantly increased in the lungs of HDM-
HFD mice compared with those of HDM-chow mice.
According to these data, HDM-induced neutrophilic
airway inflammation, AHR, and production of IL-
17A and MIP2 cytokines in the lungs were augmented
by an HFD, probably by increase in the number of lung
macrophages, which might be related to the progres-
sion of airway inflammation.
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Fig. 2. HFD augments HDM-induced neutrophilic airway inflammation, airway hyperresponsiveness, and cytokine production in the lungs. a Protocol of
HDM-induced airway inflammation in normal chow or HFDmouse model. bBody weight gain is compared among PBS-chow, HDM-chow, PBS-HFD, and
HDM-HFD mice (n = 6 in each group). c Bronchoalveolar lavage fluid analysis for total and differential cell counts among PBS-chow, HDM-chow, PBS-
HFD, and HDM-HFD mice (n = 6 in each group). The HDM-HFD group is compared with the HDM-chow group. d Airway hyperresponsiveness is
measured through assessment of airway resistance according to graded concentrations of methacholine in PBS-chow, HDM-chow, PBS-HFD, and HDM-
HFD mice (n = 6 in each group). The HDM-chow group is compared with the PBS-chow group, while the HDM-HFD group is compared with HDM-chow
mice. eHistologic examination for airway inflammation. Sections are stained with H&E (upper panels) and PAS (lower panels). Original magnification was
× 200. Concentrations of f IL-13, g IL-17A, h IL-1β, and iMIP2 in lung tissue are measured by ELISA (n = 6 in each group). *P < 0.05, **P < 0.01. HFD,
high-fat diet; HDM, house dust mite; PBS, phosphate-buffered saline; H & E, hematoxylin and eosin; PAS, periodic acid-Schiff; MIP2, macrophage
inflammatory protein 2; ELISA, enzyme-linked immunosorbent assay.
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Saturated Fatty Acids Induced In Vitro Monocyte
Chemoattractant Protein-1 and Lipopolysaccharide-
Primed Inflammatory Cytokine Production from
Macrophages
To clarify the presence of a direct interaction between
HFD and macrophages, we used in vitro assays of SFA and
several macrophages. In an official analysis of the fatty acid
profile of HFD, 37.1% comprised SFA, of which PAwas the
most common at 62.2%. Therefore, we used PA to represent
SFA and found that it induced the expression of TLR4 and
increased MCP-1 in RAW cells (Fig. 3a, b). Because HDM
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in vitro (data not shown), we cultured macrophages with PA
and LPS instead. LPS increased the levels of TNF-α and IL-
1β in RAW cells (Fig. 3c, d), BMMs (Fig. 3e, f), and
peritoneal macrophages (Fig. 3g, h); these levels were sig-
nificantly increased further by pre-incubation with PA.
These data suggested that SFA induced TLR4 expression
and macrophage recruitment and directly augmented LPS-
related inflammation. SFA was considered a factor that
affected airway inflammation in HDM-HFD mice.
Saturated Fatty Acid Administration Increased Lung
Macrophages but Not Airway Inflammation and
Airway Hyperresponsiveness in Mice
We administered PA intraperitoneally to mice [13,
26] and investigated the cell population in the lungs
(Fig. 4a). The body weights of PA-administered mice
and vehicle mice were not different (data not shown).
Circulating monocytes and alveolar macrophages were
significantly increased in the lungs of PA-administered
mice compared with those in vehicle mice (Fig. 4b–d).
BALF total cell count and differential count, as well as
AHR, were not different between PA-administered
mice and vehicle mice (data not shown). These data
suggested that similar to HFD, PA increased the num-
ber of lung macrophages, including circulating mono-
cytes and alveolar macrophages, without airway in-
flammation and AHR.
Saturated Fatty Acids Augmented House Dust Mite-
Induced Neutrophilic Inflammation, Airway
Hyperresponsiveness, and Cytokine Levels in the
Lungs
Finally, we sensitized and exposed PA-administered
mice with HDM to identify the role of SFA in the
pathogenesis of asthma (Fig. 5a). Body weight did not
differ among PBS-vehicle mice, HDM-vehicle mice,
PBS-PA mice, and HDM-PA mice (data not shown).
BALF total cell count, neutrophils, and eosinophils were
significantly higher in HDM-vehicle and HDM-PA mice
than in PBS-vehicle mice and PBS-PA mice (Fig. 5b).
Total cell count and neutrophils were significantly in-
creased in the BALF of HDM-PA mice compared with
those in HDM-vehicle mice. Eosinophils tended to be
increased in HDM-PA mice than in HDM-vehicle mice;
however, this was not significantly different (Fig. 5b).
Airway resistance was higher in HDM-vehicle mice than
in PBS mice and further increased significantly in HDM-
PA-administered mice than in HDM-vehicle mice
(Fig. 5c).
On pathologic examination of the lungs, the pres-
ence of inflammatory cells and goblet cell hyperplasia
was more intense in HDM-vehicle mice and HDM-PA-
administered mice than in PBS-vehicle mice and PBS-
PA-administered mice. The findings in HDM-PA-
administered mice tended to be more intense than those
in HDM-control mice (Fig. 5d). IL-13, IL-17A, IL-1β,
and MIP2 cytokines in lung tissue were increased in
HDM-vehicle mice and HDM-PA-administered mice
compared to PBS-vehicle mice and PBS-PA-
administered mice. IL-13 and IL-17A tended to be
higher in the lungs of HDM-PA-administered mice
than in HDM-vehicle mice, but this was not statistical-
ly significant (Fig. 5e, f). IL-1β and MIP2 significantly
increased in the lungs of HDM-PA-administered mice
compared to HDM-vehicle mice (Fig. 5g, h).
DISCUSSION
The present study demonstrated that SFA had impor-
tant roles in the augmenting the mechanisms of asthma in
obesity. Specifically, these roles included progression of
neutrophilic airway inflammation and AHR. HFD, which
comprised a large amount of SFA, increased the number of
macrophages in the lungs and exacerbated neutrophilic
airway inflammation and AHR. This observation was as-
sociated with elevation in the levels of IL-17A and MIP2
cytokines in the lungs. Moreover, intraperitoneal adminis-
tration of SFA showed similar effects with HFD mice in
increasing lung macrophages and progression of HDM-
induced neutrophilic airway inflammation and AHR, along
with increased IL-1β and MIP2 cytokines in the lungs. PA
affected not onlyMCP-1 induction but also TNF-α and IL-
1β production and TLR4 upregulation in macrophages. To
Fig. 3. PA induces TLR4 expression, MCP-1, and LPS-primed inflam-
matory cytokine production from macrophages in vitro. RAW 264.7 are
stimulated by PA (500 μM) for 8 h to isolate RNA. RAW 264.7, BMMs,
and peritoneal macrophage are stimulated for 24 h by PA (500 μM) and
LPS (100 pg/ml) to major protein level by ELISA. For cells cultured with
both PA and LPS, PA is pre-incubated 1 h before stimulation by LPS. a
TLR4 level in RAW 264.7 was measured by real-time RT-PCR assay. The
concentrations of b MCP-1, c IL-1β, and d TNF-α in the supernatant of
RAW; e IL-1β and f TNF-α in the supernatant of BMMs; and g IL-1β and
h TNF-α in the supernatant of peritoneal macrophages are shown. The
LPS-stimulated group is compared with the PA-stimulated group, while
the PA+LPS-stimulated group is comparedwith the LPS-stimulated group.
The results are representatives of two independent experiments.
**P < 0.01. TLR4, toll-like receptor 4; BMMs, bone marrow derived
macrophages; PA, palmitic acid; LPS, lipopolysaccharide;MCP-1, mono-
cyte chemoattractant protein-1; TNF-α, tumor necrosis factor α.
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the best of our knowledge, this was the first report that
clarified the augmenting mechanisms of asthma in obesity
in relation to SFA and macrophages.
In the present study, lung macrophages, including
circulating monocytes and alveolar macrophages, were
significantly increased in HFD mice and PA-administered
mice, although there was no difference in the number of
macrophages in BALF. A previous study reported that the
phenotypes of alveolar and interstitial macrophages in
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Fig. 5. PA arguments HDM-induced neutrophilic airway inflammation, airway hyperresponsiveness, and cytokine production in the lungs. a Protocol of
HDM-induced airway inflammation mouse model administered with vehicle or PA. b Bronchoalveolar lavage fluid total and differential cell counts is
compared among PBS-vehicle, HDM-vehicle, PBS-PA, and HDM-PA mice (n = 6 in each group). The HDM-vehicle group is compared with the HDM-PA
group. c Airway hyperreactivity is assessed by measuring airway resistance according to graded concentrations of methacholine in PBS-vehicle, HDM-
vehicle, PBS-PA, and HDM-PA mice (n = 6 in each group). The HDM-vehicle group is compared with the PBS-vehicle group, while the HDM-PA group is
compared with the HDM-vehicle mice. d Histologic examination for airway inflammation. Sections are stained with H & E (upper panels) and PAS (lower
panels). Original magnification was ×200. Concentrations of e IL-13, f IL-17A, g IL-1β, and hMIP2 in the lung tissue were measured by ELISA (n = 6 in
each group). *P < 0.05, **P < 0.01.HDM, house dust mite; PA, palmitic acid; PBS, phosphate-buffered saline;H& E, hematoxylin and eosin; PAS, periodic
acid-Schiff; MIP2, macrophage inflammatory protein 2; ELISA, enzyme-linked immunosorbent assay.
Fig. 4. Palmitic acid increases lung macrophages. a Protocol of vehicle-
or palmitic acid- (50 μM) administered mouse model. b Cells are identi-
fied from digested lungs; after exclusion of doublets and debris, leukocytes
are separated by CD45 staining. CD11c-negative, CD11b-positive, and
Ly6c-positive cells are identified on circulating monocytes. On the other
hand, CD11c-positive and CD11b-negative cells are identified on alveolar
macrophages. The percentages of c circulating monocytes and d alveolar
macrophages are compared between vehicle- and palmitic acid-
administered mice (n = 6 in each group). **P < 0.01.
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BALF were different from those in lung tissue [51]. We
considered that interstitial macrophages might be related to
the increasing number of macrophages in lung tissue.
Macrophages were reported as pivotal regulators of immu-
nity and inflammation in obesity and asthma [10, 32].
Mcneils et al. reported that obesity increased the recruit-
ment of tissue macrophages and led to inflammation in
adipose tissue, liver, and skeletal muscle [25]. Obesity has
been shown to regulate macrophage phenotype and to
induce inflammatory signals, such as nuclear factor-κB
and phosphatidylinositol 3-kinase [6, 49]. In addition,
SFA was shown to modulate TNF-α expression in mice
macrophage lineage and to activate inflammation through
nucleotide-binding domain, leucine-rich repeats containing
family, and pyrin domain-containing-3 inflammasome [9,
44]. Circulating and alveolar macrophages are crucial for
airway inflammation and are related to the pathogenesis of
severe asthma through LPS responsiveness [19, 31]. We
have reported that circulating macrophages, as the source
of IL-33, contributed to severe asthma [42]. The findings in
this study of increased lung macrophages in HFDmice and
PA-administered mice were consistent with those of previ-
ous studies.
In the present study, neutrophilic airway inflammation
and AHRwere augmented along with elevation of MIP2 and
IL-17A in the lungs. A previous study reported that asthmatic
patients with obesity (BMI >30) had poor asthma-specific
quality of life, poor asthma control, and frequent asthma-
related hospitalizations, compared with non-obese (BMI
<25) asthma patients [29]. Recent studies showed that innate
lymphoid cell 3-induced IL-17 production was related to
obesity-associated AHR through macrophage-derived IL-1β
[22] and that blockade of TNF-α attenuated ozone-induced
neutrophilic inflammation and AHR in obesity [48]. Addi-
tionally, PA induced islet inflammation and recruited macro-
phages withMCP-1 through TLR4 in vivo [13]. According to
these data, we considered that SFA recruited macrophages to
the lungs and caused progression of HDM-induced neutro-
philic airway inflammation in refractory asthma. This ICS-
insensitive phenotype might be a result of IL-17A and MIP2
induction, as demonstrated in this HFD mouse model.
We have shown that PA induced MCP-1 production
and exacerbation of LPS-primed inflammatory cytokine
production from macrophages. MCP-1 was reported as
an obesity-related chemokine that modulates tissue migra-
tion of macrophages [30]. In addition, obese patients were
shown to express higher plasma levels of MCP-1 than
normal patients [5, 7]. LPS, which is contained in HDM,
caused a shift from eosinophilic to neutrophilic airway
inflammation, along with elevation of IL-8; these
contributed to resistance to asthma treatment [24, 53].
According to these results, attenuation of SFA levels might
control neutrophilic airway inflammation in obese patients
with asthma. In the future, reduction of SFA-regulated
migration of lung macrophages may be a target of treat-
ment in severe asthma patients with obesity.
In conclusion, SFA induced MCP-1 production for
macrophage recruitment to the lungs and directly enhanced
LPS-induced TNF-α and IL-1β production by macro-
phages. Furthermore, SFA increased the number of lung
macrophages, augmented HDM-induced neutrophilic air-
way inflammation and AHR, and increased the levels of
IL-17A and MIP2 in HFD mice.
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